Psychiatric manifestations and personality traits associated with compliance with glaucoma treatment

Journal of Psychosomatic Research

Volumn 61, Issue 5, 2006, Pages 609-617

  Pappa, Chrisavgi ^a   Hyphantis, Thomas ^a   Pappa, Sofia ^a   Aspiotis, Miltiadis ^a   Stefaniotou, Maria ^a   Kitsos, Georgios ^a   Psilas, Konstantinos ^a   Mavreas, Venetsanos ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Compliance; Depression; Ego mechanisms of defense; Glaucoma therapy; Hostility; Personality; POAG; Psychological distress

Indexed keywords

ADULT; AGED; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; DEFENSE MECHANISM; DEPRESSION; DISEASE SEVERITY; FEMALE; GENERAL HEALTH QUESTIONNAIRE; GLAUCOMA; HIGH RISK PATIENT; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PATIENT COMPLIANCE; PERSONALITY; QUESTIONNAIRE; RISK FACTOR; SELF CONCEPT; SYMPTOM DISTRESS SCALE; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CHARACTER; CROSS-SECTIONAL STUDIES; DEFENSE MECHANISMS; DEPRESSION; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA, OPEN-ANGLE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOSTILITY; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PERSONALITY INVENTORY; SICK ROLE; TREATMENT REFUSAL;

EID: 33750456194     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2006.03.050     Document Type: Article

References (62)

1. World Health Organization (WHO). World Health Report 1997. Executive summary: Conquering suffering, enriching humanity (WHO Web site). Available at. http://www.who.int/whr2001/2001/archives/1997/exsum97e.htm
2. Pitts Crick R. Epidemiology and screening of open-angle glaucoma. Curr Opin Ophthalmol 5 (1994) 3-9
3. Quigley H. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci 38 (1997) 83-91
4. World Health Organization (WHO). World health report 2001. Mental health: new understanding, new hope (2001), WHO, Geneva, Switzerland 152-153
5. Konstas A., Maskaleris G., Gratsonidis S., and Sardelli C. Compliance and viewpoint of glaucoma patients in Greece. Eye 14 Pt 5 (2000) 752-756
6. Zimmerman T., and Zalta A. Facilitating patient compliance in glaucoma therapy. Surv Ophthalmol 28 Suppl (1983) 252-258
7. Tsai J., McClure C., Ramos S., Schlundt D., and Pichert J. Compliance barriers in glaucoma: a systematic classification. Glaucoma 12 (2003) 393-398
8. Lee M., Fechtner F., Fiscella R., Singh K., and Stewart W. Emerging perspectives on glaucoma: highlights of a roundtable discussion. Am J Ophthalmol 130 4 Suppl (2000) S1-S11
9. Ashburn F., Goldberg I., and Kass M. Compliance with ocular therapy. Surv Ophthalmol 24 (1980) 237-248
10. Davidson S., and Akingbehin T. Compliance in ophthalmology. Trans Ophthalmol Soc U K 100 Pt 2 (1980) 286-290
11. Granstrom P., and Norell S. Visual ability and drug regimen: relation to compliance with glaucoma therapy. Acta Ophthalmol (Copenh) 61 (1983) 206-219
12. Kass M., and Gordon D. The compliance factor. Glaucoma: applied pharmacology in medical treatment (1984), Grune & Stratton, New York
13. Olthoff C., Schouten J., van de Borne B., and Webers C. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology 112 (2005) 953-961
14. Spaeth G. Visual loss in a glaucoma clinic. I. Sociological considerations. Invest Ophthalmol 9 (1970) 73-82
15. Vincent P. Patients' viewpoint of glaucoma therapy. Sight Sav Rev 42 (1972) 213-221
16. Kass M. Non-compliance to ocular therapy: glaucoma report. Ann Ophthalmol 10 (1978) 1244
17. Olander K., and Zimmerman T. Practical aspects of controlling glaucoma medically or how to make your glaucoma medicines work for you. Glaucoma editorial. Ann Ophthalmol 85 (1980) 225
18. Polk I. Drug compliance in the elderly. JAMA 248 (1982) 1239
19. Montamat S., Cusack B., and Vestal R. Management of drug therapy in the elderly. N Engl J Med 321 (1989) 303-309
20. Chang J., Lee D., Petursson G., Spaeth G., Zimmerman T., Hoskins H., Mills R., Brown R., Kass M., and Lue J. The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure. J Ocul Pharmacol 7 (1991) 117-124
21. Riffenburgh R. Doctor-patient relationship in glaucoma therapy. Arch Ophthalmol 75 (1966) 204-206
22. Bloch S., Rosenthal A., Friedman L., and Caldarolla P. Patient compliance in glaucoma. Br J Ophthalmol 61 (1977) 531-534
23. Dimatteo M., Lepper H., and Croghan T. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160 (2000) 2101-2107
24. Katon W. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 54 (2003) 216-226
25. Druss B., Rosenheck A., Desai M., and Perlin J. Quality of preventative medical care for patients with mental disorders. Med Care 40 (2002) 129-136
26. Demailly P., Zoute C., and Castro D. Personalities and chronic glaucoma. J Fr Ophtalmol 12 (1989) 595-601 [French]
27. Wilson M., Coleman A., Yu F., Fong Sasaki I., Bing E., and Kimm M. Depression in patients with glaucoma as measured by self-report surveys. Ophthalmology 109 (2002) 1018-1022
28. Wiebe J., and Christensen A. Patient adherence in chronic illness: personality and coping in context. J Pers 64 (1996) 815-835
29. Caine T., Foulds G., and Hope K. Manual of Hostility and Direction of Hostility Questionnaire (1967), University of London Press, London
30. Bond M., Gardner S., Christian J., and Sigal J. Empirical study of self-rated defense styles. Arch Gen Psychiatry 40 (1983) 333-338
31. Bond M. An empirical study of defense styles: the Defense Style Questionnaire. In: Vaillant G. (Ed). Ego mechanisms of defense: a guide for clinicians and researchers (1992), American Psychiatric Press, Washington (DC)
32. Aasman P., and Heijl A. Evaluation of methods for automated hemifield analysis in perimetry. Arch Ophthalmol 110 (1992) 812-819
33. Goldberg D., and Hillier V. A scaled version of the General Health Questionnaire. Psychol Med 9 (1979) 139-145
34. Schmitz N., Kruse J., Heckrath C., Alberti L., and Tress W. Diagnosing mental disorders in primary care: the General Health Questionnaire (GHQ) and the Symptom Check List (SCL-90-R) as screening instruments. Soc Psychiatry Psychiatr Epidemiol 34 (1999) 360-366
35. Jenkinson C., and Fitzpatrick R. Measurement of health status in patients with chronic illness: comparison of the Nottingham Health Profile and the General Health Questionnaire. Fam Pract 7 (1990) 121-124
36. Garyfallos G., Karastergiou A., Adamopoulou A., Moutzoukis C., Alagiozidou E., Mala D., and Garyfallos A. Greek version of the General Health Questionnaire: accuracy of translation and validity. Acta Psychiatr Scand 84 (1991) 371-378
37. Derogatis L. SCL-90-R: administration, scoring, and procedure manual. 3rd ed. (1994), National Computer Systems, Minneapolis (MN)
38. Peebles J., McWilliams L., and MacLennan R. A comparison of symptom checklist 90-revised profiles from patients with chronic pain from whiplash and patients with other musculoskeletal injuries. Spine 26 (2001) 766-770
39. Donias S., Karastergiou A., and Manos N. Standardization of the symptom checklist-90-R rating scale in a Greek population. (in Greek with English abstract). Psychiatriki 2 (1991) 42-48
40. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1 (1977) 385-401
41. Fountoulakis K., Iacovides A., Kleanthous S., Samolis S., Kaprinis S., Sitzoglou K., Kaprinis G., and Bech P. Reliability, validity and psychometric properties of the Greek translation of the Center for Epidemiological Studies-Depression (CES-D) Scale. BMC Psychiatry 1 (2001) 3
42. Hyphantis T., Kaltsouda A., Triantafillidis J., Platis O., Karadagi S., Christou C., Mantas C., Argyropoulos A., and Mavreas V. Personality correlates of adherence to type 2 diabetes regimens. Int J Psychiatry Med 35 (2005) 103-107
43. Angelopoulos N., Drosos A., and Moutsopoulos H. Psychiatric symptoms associated with scleroderma. Psychother Psychosom 70 (2001) 145-150
44. Hyphantis T., Triantafillidis J., Pappa S., Mantas C., Kaltsouda A., Cherakakis P., Alamanos Y., Manousos O., and Mavreas V. Defense mechanisms in inflammatory bowel disease. J Gastroenterol 40 (2005) 24-30
45. Lane J., McCaskill C., Williams P., Parekh P., Feinglos M., and Surwit R. Personality correlates of glycemic control in type 2 diabetes. Diabetes Care 23 (2000) 1321-1325
46. Vagenakis G., Hyphantis T., Papageorgiou C., Protonatariou A., Sgourou A., Dimopoulos P., Mavreas V., Vagenakis A., and Georgopoulos N. Kallmann's syndrome and schizophrenia. Int J Psychiatry Med 34 (2004) 379-390
47. Deokule S., Sadiq S., and Shah S. Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms. Ophthalmic Physiol Opt 24 (2004) 9-15
48. Priest R. The homeless person and the psychiatric services: an Edinburgh survey. Br J Psychiatry 128 (1976) 128-136
49. MacKean J., and Elkington A. Compliance with treatment of patients with chronic open-angle glaucoma. Br J Ophthalmol 67 (1983) 46-49
50. Patel S., and Spaeth G. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 26 (1995) 233-236
51. Norell S. Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Soc Sci Med 15 (1981) 57-61
52. Stimson G. Obeying doctor's orders: a view from the other side. Soc Sci Med 8 (1974) 97-104
53. Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J 130 3 Pt 1 (1995) 572-579
54. Granstrom P. Progression of visual field defects in glaucoma. Relation to compliance with pilocarpine therapy. Arch Ophthalmol 103 (1985) 529-531
55. Gurwitz J., Yeomans S., Glynn R., Lewis B., Levin R., and Avorn J. Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma. Med Care 36 3 (1998) 357-369
56. Allgower A., Wardle J., and Steptoe A. Depressive symptoms, social support, and personal health behaviors in young men and women. Health Psychol 20 3 (2001) 223-227
57. Arnsten J., Gelfand J., and Singer D. Determinants of compliance with anticoagulation: a case-control study. Am J Med 103 1 (1997) 11-17
58. DiMatteo M. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 23 2 (2004) 207-218
59. Kass M., Hodapp E., Gordon M., Kolker A., and Goldberg I. Patient administration of eyedrops: observation. Part II. Ann Ophthalmol 14 9 (1982) 889-893
60. Wing R., Phelan S., and Tate D. The role of adherence in mediating the relationship between depression and health outcomes. J Psychosom Res 53 4 (2002) 877-881
61. O'Brien M., Petrie K., and Raeburn J. Adherence to medication regimens: updating a complex medical issue. Med Care Rev 49 4 (1992) 435-454
62. DiMatteo M., Robinson J., Heritage J., Tabbarah M., and Fox S. Correspondence among patients' self-reports, chart records, and audio/videotapes of medical visits. Health Commun 15 4 (2003) 393-413